The CD8 antigen is a well-recognized marker of the cytotoxic T lymphocytes (CTLs, cytotoxic CD8+ T-cells) [5], which are considered a backbone of cancer immunotherapy [6]. The gene discussed is CD8A; the disease is cancer.